Received Mar 19, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARCEL | VARICELLA (VARIVAX) | MERCK & CO. INC. | UNK | X007373 | OT |
No additional adverse event; HCP called to report a patient received an expired dose of VARIVAX. The expiration date was 03/12/2025 and the product was administered 03/14/2025. No side effects or symptoms reported. Caller verified no temperature excursions occurred. No Additiona; This spontaneous report was received from a registered nurse and refers to a 15-month-old female patient. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On 14-MAR-2025, the patient was vaccinated with an expired dose of varicella virus vaccine live (Oka-Merck) (VARIVAX) injection, 0.5 ml, lot #X007373, expiration date: 12-MAR-2025 (dose number, route of administration and anatomical location were not provided), for prophylaxis (Expired product administered). The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) (route of administration, anatomical location, lot# and expiration date were not reported). No side effects or symptoms reported. The reporter verified no temperature excursions occurred and requested to review stability information. No additional adverse event was reported (No adverse event).
sterile diluent